We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current AFP market cap is 298.87M. The company's latest EPS is NZD 0.1016 and P/E is 28.05.
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
| Total Revenue | 85.13M | 105.6M | 113.11M | 130.31M | 156.64M |
| Operating Income | 6.12M | 21.21M | 10.71M | 20.39M | 19.67M |
| Net Income | -2.43M | 12.69M | 7.78M | 19.85M | 10.65M |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
| Total Assets | 63.6M | 87.05M | 105.13M | 121.76M | 148.06M |
| Total Liabilities | 58.5M | 69.8M | 68.54M | 65.02M | 74.8M |
| Total Equity | 5.09M | 17.26M | 36.59M | 56.74M | 73.27M |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
| Operating | 1.07M | 14.88M | 750k | 14.15M | 11.63M |
| Investing | -4.88M | -6.56M | -6.23M | -5.59M | -9.18M |
| Financing | 3.72M | -9.12M | 2.52M | -3.91M | -6.98M |
| Market Cap | 298.87M |
| Price to Earnings Ratio | 28.05 |
| Price to Sales Ratio | 1.91 |
| Price to Cash Ratio | 62.91 |
| Price to Book Ratio | 4.08 |
| Dividend Yield | - |
| Shares Outstanding | 104.87M |
| Average Volume (1 week) | 867 |
| Average Volume (1 Month) | 1.22k |
| 52 Week Change | -10.94% |
| 52 Week High | 3.70 |
| 52 Week Low | 2.50 |
| Spread (Intraday) | 0.04 (1.4%) |
| Company Name | AFT Pharmaceuticals Limited |
| Address |
level 1 auckland |
| Website | https://www.aftpharm.com |
| Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
